Search
Now showing items 1-9 of 9
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2018-02-06)
Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Decorin binding protein compositions
(United States. Patent and Trademark Office, 2001-05-08)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
DbpA compositions
(United States. Patent and Trademark Office, 2001-04-10)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2019-06-25)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Decorin binding protein compositions and methods of use
(United States. Patent and Trademark Office, 2001-06-19)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
DbpA compositions and methods of use
(United States. Patent and Trademark Office, 2001-11-06)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
Decorin binding protein compositions and methods of use
(United States. Patent and Trademark Office, 1998-12-29)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
(United States. Patent and Trademark Office, 2018-05-08)
The invention provides improvements of lantibiotics useful for reducing the numbers of microbes or the reproduction of microbes in or on subjects or objects. One embodiment of the invention provides variants of antibiotics ...
Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
(United States. Patent and Trademark Office, 2020-06-16)
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...